{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:54:23Z","timestamp":1780595663411,"version":"3.54.1"},"reference-count":33,"publisher":"Society of Nuclear Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.2967\/jnumed.118.209916","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T08:02:15Z","timestamp":1525420935000},"page":"1869-1876","source":"Crossref","is-referenced-by-count":95,"title":["Characterization of 3 Novel Tau Radiopharmaceuticals,\n                    <sup>11<\/sup>\n                    C-RO-963,\n                    <sup>11<\/sup>\n                    C-RO-643, and\n                    <sup>18<\/sup>\n                    F-RO-948, in Healthy Controls and in Alzheimer Subjects"],"prefix":"10.2967","volume":"59","author":[{"given":"Dean F.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Comley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Ostrowitzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Boess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine G.","family":"Lyketsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Honer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noble","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Gapasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Kitzmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Sevigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayon","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakradhar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Thambisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Moghekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Dannals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilio","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"2021051712124335000_59.12.1869.1","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1021\/acs.jmedchem.7b00632","article-title":"Identification of three novel radiotracers for imaging aggregated tau in Alzheimer\u2019s disease with positron emission tomography","volume":"60","author":"Gobbi","year":"2017","journal-title":"J Med Chem."},{"key":"2021051712124335000_59.12.1869.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.196741"},{"key":"2021051712124335000_59.12.1869.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2015.09.002"},{"key":"2021051712124335000_59.12.1869.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.10.007"},{"key":"2021051712124335000_59.12.1869.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1789.2004.00571.x"},{"key":"2021051712124335000_59.12.1869.6","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2015.1075002"},{"key":"2021051712124335000_59.12.1869.7","doi-asserted-by":"crossref","first-page":"3245935","DOI":"10.1155\/2016\/3245935","article-title":"Tau-centric targets and drugs in clinical development for the treatment of Alzheimer\u2019s disease","volume":"2016","author":"Panza","year":"2016","journal-title":"BioMed Res Int."},{"key":"2021051712124335000_59.12.1869.8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11481-015-9637-6","article-title":"Tau-directed immunotherapy: a promising strategy for treating Alzheimer\u2019s disease and other tauopathies","volume":"11","author":"Schroeder","year":"2016","journal-title":"J Neuroimmune Pharmacol."},{"key":"2021051712124335000_59.12.1869.9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jalz.2015.08.013","article-title":"First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 [abstract]","volume":"11(suppl)","author":"Wong","year":"2015","journal-title":"Alzheimers Dement."},{"key":"2021051712124335000_59.12.1869.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.wad.0000137520.23370.56"},{"key":"2021051712124335000_59.12.1869.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.037762"},{"key":"2021051712124335000_59.12.1869.12","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/50\/20\/010"},{"key":"2021051712124335000_59.12.1869.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.214437"},{"key":"2021051712124335000_59.12.1869.14","unstructured":"Friston KJ . Introduction: experimental design and statistical parametric mapping. In: Frackowiak RSJ Friston KJ Frith C , eds. Human Brain Function. 2nd ed. Cambridge, MA: Academic Press; 2003:599\u2013634."},{"key":"2021051712124335000_59.12.1869.15","unstructured":"Ashburner J Friston KJ . Rigid body registration. In: Frackowiak RSJ Friston KJ Frith C , eds. Human Brain Function. 2nd ed. Cambridge, MA: Academic Press; 2003:635\u2013654."},{"key":"2021051712124335000_59.12.1869.16","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1990.127"},{"key":"2021051712124335000_59.12.1869.17","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199609000-00008"},{"key":"2021051712124335000_59.12.1869.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.01.021"},{"key":"2021051712124335000_59.12.1869.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-006-0127-z"},{"key":"2021051712124335000_59.12.1869.20","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww023"},{"key":"2021051712124335000_59.12.1869.21","first-page":"748","article-title":"Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition","volume":"140","author":"Pontecorvo","year":"2017","journal-title":"Brain."},{"key":"2021051712124335000_59.12.1869.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.197426"},{"key":"2021051712124335000_59.12.1869.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.171678"},{"key":"2021051712124335000_59.12.1869.24","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/acs.jmedchem.6b00166","article-title":"Discovery of 6-(fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs)","volume":"59","author":"Walji","year":"2016","journal-title":"J Med Chem."},{"issue":"suppl 1","key":"2021051712124335000_59.12.1869.25","first-page":"848","article-title":"Assessing optimal injected dose for tau PET imaging using [18F]GTP1 (Genentech Tau Probe 1) [abstract]","volume":"58","author":"Sanabria Bohorquez","year":"2017","journal-title":"J Nucl Med."},{"issue":"suppl","key":"2021051712124335000_59.12.1869.26","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1016\/j.jalz.2017.06.2625","article-title":"First-in-human PET studies with the next generation tau agent 18-F PI-2620 in Alzheimer\u2019s disease, progressive supranuclear palsy, and controls","volume":"13","author":"Barret","year":"2017","journal-title":"Alzheimers Dement."},{"key":"2021051712124335000_59.12.1869.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.185199"},{"key":"2021051712124335000_59.12.1869.28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"2021051712124335000_59.12.1869.29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24711"},{"key":"2021051712124335000_59.12.1869.30","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww027"},{"key":"2021051712124335000_59.12.1869.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.01.028"},{"key":"2021051712124335000_59.12.1869.32","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809"},{"key":"2021051712124335000_59.12.1869.33","doi-asserted-by":"crossref","first-page":"P139","DOI":"10.1016\/j.jalz.2017.06.2563","article-title":"On evaluation of tau accumulations in longitudinal studies of Alzheimer\u2019s disease (AD): implications from a PET study with [18F]RO6958948 [abstract]","volume":"13","author":"Kuwabara","year":"2017","journal-title":"Alzheimers Dement."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.209916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:32:28Z","timestamp":1621269148000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.209916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,3]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.2967\/jnumed.118.209916"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.209916","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/296764","asserted-by":"object"}]},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]}}}